Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
434.13
Oct 21 • 3:59 PM ET Dollar change-6.05 Percentage change(-1.37%)
Aftermarket Close
434.48
Aftermarket • 7:45 PM ET Dollar change+0.35 Percentage change(0.08%)
Oct 21, 12:03 PMElevance Health beats Q3 and raises 2026 EPS guidance and 2027 baseline on Medicaid, Medicare Advantage and ACA margin outperformance
Index
S&P 500
Market Cap
94.15B
Enterprise Value
-
Income
5.14B
Sales
201.83B
Book/sh
206.75
Cash/sh
-
Employees
97100
IPO
Oct 30, 2001
P/E
18.51
Forward P/E
14.54
PEG
3.44
P/S
0.47
P/B
2.10
P/C
-
P/FCF
14.45
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
1.47
Debt/Eq
0.69
LT Debt/Eq
0.68
Option/Short
Yes / Yes
EPS (ttm)
23.46
EPS next Y
29.86
EPS next Q
2.30
EPS this Y
-7.93%
EPS next Y
7.09%
EPS next 5Y
4.23%
EPS past 3/5Y
1.27% 6.99%
Sales past 3/5Y
8.34% 10.32%
EPS Y/Y TTM
-4.37%
Sales Y/Y TTM
3.60%
EPS Q/Q
18.02%
Sales Q/Q
1.42%
Insider Own
0.23%
Insider Trans
0.34%
Inst Own
94.72%
Inst Trans
0.73%
ROA
4.10%
ROE
11.60%
ROIC
6.85%
Gross Margin
-
Oper. Margin
3.81%
Profit Margin
2.55%
SMA20
6.04%
SMA50
6.85%
SMA200
17.21%
Trades
Shs Outstand
216.87M
Shs Float
216.36M
52W High
440.67 -1.48%
52W Low
274.84 57.96%
Volatility
2.78% 2.64%
ATR (14)
11.30
RSI (14)
66.37
Beta
0.65
Rel Volume
2.19
Avg Volume
1.13M
Volume
2,475,615
Perf Week
1.41%
Perf Month
7.88%
Perf Quarter
14.45%
Perf Half Y
32.28%
Perf YTD
23.84%
Perf Year
24.13%
Perf 3Y
-4.33%
Perf 5Y
0.86%
Perf 10Y
251.52%
Prev Close
440.18
Price
434.13
Change %
-1.37%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERU RAMIRO GDirectorJul 17 '26Buy366.051,000366,05010,908Jul 17 03:04 PM
BOUDREAUX GAILPresident and CEOJul 17 '26Buy367.792,7251,002,230171,976Jul 17 01:50 PM
CLARK R KERRYDirectorJul 07 '26Proposed Sale419.911,500629,865Jul 07 04:58 PM
Penczek Ronald WCAO & ControllerJun 12 '26Sale403.16369148,7663,740Jun 15 04:10 PM
RONALD WILLIAM PENCZEKOfficerJun 12 '26Proposed Sale403.16369148,767Jun 12 05:27 PM
Dixon Robert L JRDirectorJun 11 '26Sale401.7715160,66710,734Jun 12 04:12 PM
Dixon Robert L JRDirectorJun 11 '26Proposed Sale401.7615160,666Jun 11 05:10 PM
Penczek Ronald WCAO & ControllerMay 19 '26Option Exercise294.301,531450,5795,640May 20 04:11 PM
Penczek Ronald WCAO & ControllerMay 19 '26Sale403.131,531617,1924,109May 20 04:11 PM
RONALD WILLIAM PENCZEKOfficerMay 19 '26Proposed Sale403.131,531617,192May 19 04:25 PM
SCHULMAN AMY WDirectorMar 12 '26Sale287.50267,475218Mar 23 04:10 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 06 '26Sale284.923,196910,60411,791Mar 09 04:45 PM
CHARLES MORGAN KENDRICKOfficerMar 06 '26Proposed Sale284.923,196910,593Mar 06 04:17 PM
COLLIS STEVEN HDirectorMar 05 '26Buy289.843,000869,5203,639Mar 06 08:03 AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
PresidentMs. Gail Koziara Boudreaux
Executive VP & CFOMr. Mark Bradley Kaye
Special AdvisorMr. Peter David Haytaian Esq.
EVP and President of Commercial & Specialty Health BenefitsMr. Charles Morgan Kendrick Jr.
Executive VP & Chief Health Benefits OfficerMs. Felicia Farr Norwood